International trends in hepatocellular carcinoma incidence, 1978

International trends in hepatocellular carcinoma incidence, 1978–2012

Published:2019-11-05 Issue:2 Volume:147 Page:317-330
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Petrick Jessica L.¹²^ORCID,Florio Andrea A.¹,Znaor Ariana³^ORCID,Ruggieri David⁴,Laversanne Mathieu³,Alvarez Christian S.¹,Ferlay Jacques³,Valery Patricia C.⁵,Bray Freddie³,McGlynn Katherine A.¹^ORCID

Affiliation:

1. Division of Cancer Epidemiology and GeneticsNational Cancer Institute Bethesda MD

2. Slone Epidemiology CenterBoston University Boston MA

3. Cancer Surveillance SectionInternational Agency for Research on Cancer Lyon France

4. Information Management Services, Inc Rockville MD

5. QIMR Berghofer Medical Research Institute Brisbane Australia

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32723

Reference54 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Histological classification of liver and intrahepatic bile duct cancers in SEER registries;Altekruse SF;J Registry Manag,2011

3. Global trends and predictions in hepatocellular carcinoma mortality

4. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

5. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention

Cited by 366 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring extrahepatic metastasis of hepatocellular carcinoma based on methylation driver genes and establishing a prognostic model for hepatocellular carcinoma;Gene;2025-01

2. Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma;Translational Oncology;2024-10

3. Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer;Cancer Letters;2024-10

4. Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

5. Retrospective analysis of patients with hepatocellular carcinoma complicated with human immunodeficiency virus infection after hepatectomy;World Journal of Gastrointestinal Oncology;2024-09-15